Melanoma and Cutaneous Malignancy Tumor Board
2/15/17
12:00-1:00PM
PCAM South Tower Room 10-122
Moderators: Dr. Lynn Schuchter, Dr. Giorgos Karakousis, and Dr. Gangadhar
Target Audience
This program has been designed for physicians, fellows, residents, medical students, physician assistants, professional nurses, advance practice nurses, researchers, and social workersin dermatology, medical genetics and genomics, pathology, radiology, surgery, oncologic surgery, dermatologic surgery, oncology, ENT, and radiation oncology
Series Educational Objectives
After completing this activity, participants should be able to:
- Provide a multidisciplinary approach to care for patients with melanoma and other cutaneous malignancies
- Develop a plan for accurate diagnosis, complete staging and treatment for patients with melanoma and other cutaneous malignancies
- Treat and manage patients with melanoma and other cutaneous malignancies
- Review current literature and research relating to melanoma and other cutaneous malignancies
Accreditation
Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses: Penn Medicine Nursing is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval # 124-3-H-15
Designation of Credit
Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Nurse participants will be awarded 1.0 contact hour.
PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.
Approved for (PSRM) patient safety/risk management designation
Acknowledgement of Commercial Support* NONE
For more information, please contact
Leonardo Antelo
215-360-0911
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Developmentfor individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME,Zalman Agus, MD,Senior peer reviewerand Patricia A. Smith, DNP, RN-BC,Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Planning Committee Member & Presenter Name
Lynn Schucter, MD / Leonardo Antelo, BS / Hayley Cassidy, CRNPLeonardo Antelo
Presenter Name
Peter Ahn, MD / Ravi Amaravadi, MD / Christine Cambareri, PharmD / Po-Hao Chen, MDEmily Chu, MD, Phd / Jacob Dubroff, MD, PHD / David Elder, MB, ChB / Michael Farwell, MD
Lydia Giles, RN / Kristin Kreider, PA-C / Goldie Kurtz, MD / David Mankoff, MD
Hayley Miller / Philipose G. Mulugeta, MD / Ilya Nascallah, MD, PhD / Jagruti Shah
Thuzar Myo Shin, MD, PHD / Xiaowei Xu, MD PhD
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
Planning Committee & Presenter NameName of Commercial InterestRelationship
Giorgios Karakousis, MDCastle BiosciencesCosultant
Tara Gangadhar, MDMerckSAC
BMS, IncyteResearch
Suzanne McGettigan, CRNPMerck, BMS, Novartis, GementechSpeaker
Presenter NameName of Commercial InterestRelationship
Rosalie Elenitsasm, MDMyriad GeneticsConsultant
Daniel Pryma, MDBayer, Progenics, AAAResearch
Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected
Disclosure of Unapproved Uses of Products
Presenter nameProductInvestigational and/or Off-label Use